Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. TECHNESCAN HDP FOR INJECTION 3 MG/VIAL [SIN12151P]

TECHNESCAN HDP FOR INJECTION 3 MG/VIAL [SIN12151P]

Active ingredients: TECHNESCAN HDP FOR INJECTION 3 MG/VIAL

Last updated 26 October 2025

Product Info

TECHNESCAN HDP FOR INJECTION 3 MG/VIAL

[SIN12151P]

Product information

Active Ingredient and Strength

SODIUM OXIDRONATE - 3 MG/VIAL

Dosage Form

INJECTION, POWDER, FOR SOLUTION

Manufacturer and Country

CURIUM NETHERLANDS B.V. - NETHERLANDS

Registration Number

SIN12151P

Licence Holder

QT INSTRUMENTS (S) PTE LTD

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

V09BA01

Therapeutic indications
After reconstitution with Sodium Pertechnetate (99mTc) Injection (Fission or Non-Fission) the agent may be used for bone scintigraphy, where it delineates areas of altered osteogenesis.

Posology and method of administration
The average activity administered by single intravenous injection is 500 MBq (300 – 700 MBq) in a 50 to 70 kg adult. Other activities may be justifiable. There is no special dosage regimen for the elderly patient. The dose to be administered to a child should be a fraction of the adult dose calculated from the body weight according to the following table.

Technescan HDP For Injection Dosage Table 1



In very young children (up to 1 year) a minimum dose of 40 MBq is necessary in order to obtain images of sufficient quality.

Images obtained shortly after injection (e.g. in the so-called "3-phase bone scan" procedure) will only partly reflect metabolic activity. Late phase static scintigraphy should be performed not earlier than 2 hours after injection. The patient should void before scanning.

Contra-indications
There are no specific contra-indications.